𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations

✍ Scribed by Marcela Gallardo; Antonia Silva; Lorena Rubio; Carolina Alvarez; Carolina Torrealba; Mauricio Salinas; Teresa Tapia; Paola Faundez; Lorena Palma; María Eugenia Riccio; Hernando Paredes; Mario Rodriguez; Adolfo Cruz; Christine Rousseau; Mary Claire King; Mauricio Camus; Manuel Alvarez; Pilar Carvallo

Publisher
Springer US
Year
2005
Tongue
English
Weight
180 KB
Volume
95
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low incidence of BRCA1 mutations among I
Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer
✍ Manuela Santarosa; Alessandra Viel; Riccardo Dolcetti; Diana Crivellari; Maria D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 2 views

Most familial breast or ovarian cancers are thought to be due to highly penetrant mutations in the predisposing genes BRCA1 and BRCA2. The cloning of these genes has opened a new era for the genetic counseling of women with a family history of breast or ovarian cancer. To estimate the incidence of d

Germline mutations of BRCA1 and BRCA2 in
Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families
✍ Hio Chung Kang; Il-Jin Kim; Jae-Hyun Park; Hyuk-Jun Kwon; Yong-Jin Won; Seung Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Germline mutations in the BRCA1 and BRCA2 genes are responsible for the predisposition and development of familial breast and/or ovarian cancer. Most mutations of BRCA1 and BRCA2 associated with breast and/or ovarian cancer result in truncated proteins. To investigate the presence of BRCA1 and BRCA2

Association between BRCA1 and BRCA2 muta
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing
✍ Miguel de la Hoya; Ana Osorio; Javier Godino; Sara Sulleiro; Alicia Tosar; Pedro 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 86 KB 👁 1 views

## Abstract Index cases from a clinically relevant cohort of 102 Spanish families with at least 3 cases of breast and/or ovarian cancer (at least 1 case diagnosed before age 50) in the same lineage were screened for germline mutations in the entire coding sequence and intron boundaries of the breas

BRCA1 and BRCA2 mutation analysis in bre
BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland
✍ Magdalena Perkowska; Izabela BroŻek; Barbara Wysocka; Karin Haraldsson; Therese 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for germline mutations in BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185), using a combination of protein truncation test, denaturing high-performance liquid chromatography and direct sequencing. Sixteen (27%)

Novel germline mutations in the BRCA1 an
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families
✍ Mani T. Valarmathi; Meenakshi Sawhney; Suryanarayana S. V. Deo; Nootan K. Shukla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

The two major hereditary breast/ovarian cancer predisposition tumor suppressor genes, BRCA1 and BRCA2 that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are altered, or mutated in the germline. However, little is known abo

Novel germline BRCA1 and BRCA2 mutations
Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic
✍ Eva Machackova; Jiri Damborsky; Dalibor Valik; Lenka Foretova 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 3 views

## Communicated by Mark H. Paalman Germline mutations in breast cancer susceptibility genes, BRCA1 and BRCA2, are responsible for a substantial proportion of high-risk breast and breast/ovarian cancer families. To characterize the spectrum of BRCA1 and BRCA2 mutations, we screened Czech families w